Financials

News Discussions Seasonals

8I7 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Gemina Laboratories Ltd. engages in the development of a platform for detecting pathogens that affect humans and animals. It focuses on the development of novel surface functionalization chemistries for the detection of pathogens and biomarkers. The company was founded by John Davies on October 10, 2017 and is headquartered in Vancouver, Canada.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

8I7 does not pay dividends

The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company